VACCINEX INC
For the period ended Dec 31, 2023. Filed Apr 2, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 2, 2024
VCNX$1.41-61.4%Stored close · as of Dec 17, 2024
Opening this filing…
The words and numbers in each frame are the filing's, as the company filed them with the SEC. Where a filing is data, we made the labels and headings from its field names, and added commas to its long numbers. This is not investment advice.